Chapters

Transcript

Video

New Keys to Cancer Care: How 2023 Findings Impact Treatment Decisions

These four collaborative talks from UCSF and John Muir Health specialists shine a light on recent study results that should inform treatment planning for patients with a variety of GI, breast, lung and blood cancers. Here's guidance on care for locally advanced rectal cancer, including strategies for reducing harm (such as from pelvic radiation); results from studies of CDK4/6 inhibitors in HR+ breast cancer and ways to reduce side effects without losing benefits; an explanation of how effective use of pembrolizumab or osimertinib can optimize care in early-stage lung cancer; and the scoop on three newly approved bispecific antibodies for lymphomas – who they’re for, how they’re given, the data on efficacy and safety – as well as immune therapies for multiple myeloma.


Published

January 24, 2024

Created by

UCSF MedConnection

Related Presenters

Geoffrey Buckle, MD, MPH

Geoffrey Buckle, MD, MPH

Gastrointestinal oncologist

View full profile

Jo Chien, MD

Jo Chien, MD

Breast oncologist
Medical Director, Breast Medical Oncology

View full profile

Michael L. Cheng, MD

Michael L. Cheng, MD

Thoracic medical oncologist

View full profile